IL28B rs12979860 polymorphism and zinc supplementation affect treatment outcome and liver fibrosis a...
IL28B rs12979860 polymorphism and zinc supplementation affect treatment outcome and liver fibrosis after direct-acting antiviral hepatitis C therapy
About this item
Full title
Author / Creator
Publisher
Cairo: Springer
Journal title
Language
English
Formats
Publication information
Publisher
Cairo: Springer
Subjects
More information
Scope and Contents
Contents
Impact of interleukin 28B (IL28B) rs12979860 polymorphism on response to direct-acting antivirals agents in HCV genotype 4-infected patients is under investigation. Zinc may have an advantage in improvement of liver damage and treatment outcome. We aimed to evaluate IL28B polymorphism and zinc administration impact on patient response to treatment...
Alternative Titles
Full title
IL28B rs12979860 polymorphism and zinc supplementation affect treatment outcome and liver fibrosis after direct-acting antiviral hepatitis C therapy
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8501168
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8501168
Other Identifiers
ISSN
1687-157X
E-ISSN
2090-5920
DOI
10.1186/s43141-021-00250-y
